期刊文献+

抗可溶性肝抗原/肝胰抗原抗体阳性的肝病患者临床与实验室特征 被引量:2

Clinical and laboratory characteristics of anti-soluble liver antigen/liver-pancreas(SLA/LP)autoantibody positive liver disease patients
原文传递
导出
摘要 目的 研究肝功能异常伴抗可溶性肝抗原/肝胰抗原(SLA/LP)抗体阳性患者临床与实验 室特点。方法 收集肝功能异常患者血清5500例,分别完成相关自身抗体的检测。结果 8例(0.15%) 患者榆测出 SLA/LP 抗体阳性,女性6例,以中老年女性为主,男性2例,年龄分别为27岁和33岁,8例 中6例无甲、乙、丙、丁、戊型等病毒性肝炎现症感染证据,2例分别伴乙、丙型肝炎病毒标志物,无现症 感染证据。8例中7例已发展至肝硬化,除 SLA/LP 抗体阳性外,抗核抗体均为阳性,部分患者伴抗平滑肌 抗体,抗线粒体抗体,抗线粒体抗体亚型-丙酮酸脱氧酶复合物阳性。结论 SLA/LP 抗体在所检测患者 中阳性率较低,以女性患者为主,多数临床与实验室特点符合自身免疫性肝炎特征,女性患者慢性肝病原 因未名者应检测此抗体。 Objective To analyze the clinical and laboratory features of anti-soluble liver antigen/liver-pancreas (SLA/LP) autoantibody positive patients with abnormal liver functions. Methods From September 1999 to June 2004, 5500 serum samples from patients with abnormal liver functions (ALT 〉 40 U/L) were collected. A series of autoantibody examinations was carried out. Clinical manifestations and laboratory findings of 8 patients with anti-SLA/LP autoantibody positive were reviewed. Results Among the 5500 serum samples, 8 cases (6 females and 2 males) with positive anti-SLA/LP autoantibodies were found with complete clinical information. The age of the patients was (27-76) years old. The case histories were from 2 years to 10 years. Of the 8 patients, 6 cases had liver cirrhosis and HBsAgnegative and anti-HCV-negative, 1 case had liver cirrhosis with HBsAg-positive, but HBVDNA negative; 1 case had anti- HCV positive, but HCV RNA negative. The 8 cases were all ANA positive with titers of 1:320. Four cases were AMA positive and 2 of these 4 cases were M2 positive. The most frequent symptoms were fatigue, anorexia, nausea, jaundice, abdominal distention and edema of lower limbs. All patients had high hypergammaglobulinemia. Conclusion Anti-SLA/ LP autoantibody was at a low detection rate in the study with females in preponderance, Clinical and laboratory characteristics of the 8 cases were consistent with those of the autoimmune hepatitis (AIH). Testing for anti-SLA autoantibodies helps in the diagnosis of AIH in many patients who may otherwise be misdiagnosed.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2005年第12期927-929,共3页 Chinese Journal of Hepatology
基金 北京市科委技划项目(HO20920020190)
关键词 肝炎 自身免疫性 肝疾病 抗可溶性肝抗原/肝胰抗原 Hepatitis, autoimmune Liver diseases Anti-soluble liver antigen/liver-pancreas
  • 相关文献

参考文献10

  • 1Miyakawa H, Kawashima Y, Kitazawa E, et al. Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay. J Autoimmun, 2003, 21: 77-82. 被引量:1
  • 2阎惠平,Winfried Stcker,贺立香,张世斌,李秀惠,黄德庄,赵春惠.不同肝病患者抗肝抗原自身抗体的研究[J].中华微生物学和免疫学杂志,2002,22(5):522-525. 被引量:30
  • 3Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol, 1999, 31: 929-938. 被引量:1
  • 4中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14010
  • 5Kanzler S, Weidemann C, Gerken G, et al. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. J Hepatol, 1999, 31: 635-640. 被引量:1
  • 6Wies I, Brunner S, Henninger J, et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet,2000, 355: 1510-1515. 被引量:1
  • 7Ballot E, Homberg JC, Johanet C. Antibodies to soluble liver antigen:an additional marker in type 1 auto-immune hepatitis. J Hepatol,2000, 33: 208-215. 被引量:1
  • 8Herkel J, Heidrich B, Nieraad N, et al. Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas. Hepatology, 2002,35: 403-408. 被引量:1
  • 9Czaja AJ, Shums Z, Norman GL. Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitis. Autoimmunity, 2002, 35: 475-483. 被引量:1
  • 10刘燕敏,闫惠平,汪俊韬.肝功能异常患者中自身抗体及自身免疫性肝病的检测[J].中华肝脏病杂志,2004,12(6):360-362. 被引量:47

二级参考文献14

  • 1Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.Hepatology, 2000, 31: 1005-1013. 被引量:1
  • 2Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmane hepatitis. J Hepatol, 1999, 31: 929-938. 被引量:1
  • 3Leung PS, Van de Water J, Coppel RL, et al. Molecular aspects and the pathological basis of primary biliary cirrhosis. J Autoimmun,1996, 9: 119-128. 被引量:1
  • 4Metcalf JV, Mitchison HC, Palmer JM, et al. Natural history of early primary biliary cirrhosis. Lancet, 1996,348: 1399-1402. 被引量:1
  • 5Thomsen BL, Sorensen TI. Analysis of the treatment effect on recurrent bleeding and death in patients with cirrhosis and esophageal varices: multistage competing-risks model compared to conventional methods. J Hepatol, 1998, 28: 107-114. 被引量:1
  • 6McFarlane IG. Lesson aboutantibodies in autoimmune hepatitis. Lancet, 2000, 355: 1475-1476. 被引量:1
  • 7International Autoimmune Hepatitis Group Report: Review of Criteria for Diagnosisof Autoimmune Hepatitis. J Hepatol, 1999, 31: 929-938. 被引量:1
  • 8Wies I, Brunner S, Henninger J, et al. Identification of target antigen for SLA/LPautoantibodies in autoimmune hepatitis. Lancet, 2000, 355: 1510-1515. 被引量:1
  • 9Lapierre P, Hajoui O, Homberg JC, et al. Formiminotransferase cyclodeaminase is anorgan-specific autoantigen recognized by sera of patients with autoimmune hepatits.Gastroenterology, 1999, 116: 643-649. 被引量:1
  • 10Lohse AW, Meyer zum Buschenfelde KH, Franz B, et al. Characterization of theoverlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence forit being a hepatitic form of PBC in genetically susceptible individuals. Hepatology, 1999,29: 1080-1084. 被引量:1

共引文献14070

同被引文献16

  • 1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 2赵艳,闫惠平,檀玉芬,冯霞,刘妍,崔丹,马冬梅,李伟华,张海萍.抗可溶性肝抗原/肝胰抗原抗体在自身免疫性肝炎诊断及分型中的意义[J].中华肝脏病杂志,2007,15(4):283-286. 被引量:26
  • 3Peters MG. Animal models of autoimmune liver disease. Immunol Cell Biol, 2002, 80:113-116. 被引量:1
  • 4Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol, 1999, 31: 929-938. 被引量:1
  • 5Lohse AW, Gerken G, Mohr H, et al. Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients. Z Gastroenterol, 1995, 33: 527-533. 被引量:1
  • 6Manns M, Gerken G, Kyriatsoulis A, et al. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet, 1987, 1 : 292-294. 被引量:1
  • 7Wies I, Brunner S, Henninger J, et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet, 2000, 355: 1510-1515. 被引量:1
  • 8Czaja A J, Donaldson PT, Lohse AW. Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis. Am J Gastroenterol, 2002, 97:413-419. 被引量:1
  • 9Herkel J, Heidrich B, Nieraad N, et al. Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas. Hepatology, 2002, 35: 403-408. 被引量:1
  • 10Czaja AJ, Homburger HA. Autoantibodies in liver disease. Gastroenterology, 2001, 120: 239-249. 被引量:1

引证文献2

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部